CD19 and neoplasm: Furthermore, we found that factors such as BM tumor burden before CAR-T therapy, IPI score, and existing CNS invasion related to the type of diseases were associated with viral infection after CD19 CAR-T therapy without statistical significance using a preliminary Mann–Whitney U-test and χ2.